Delivery Order SPE2DR25D9903-SPE2DR26FGRZ2
Award Date 3/31/26
Potential Completion Date 4/1/26
Potential Value $4.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $394,301.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Pralidoxime Chloride. This delivery order, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,444.88 delivery order to DMS Pharmaceutical Group Inc. on March 19, 2026, for antidote treatment products. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations worldwide. DMS...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,444.88 delivery order to DMS Pharmaceutical Group Inc. on March 19, 2026, for antidote treatment supplies, with an ultimate completion date of April 3, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable distribution to Department of Defense healthcare facilities worldwide....
- The Defense Logistics Agency's Medical Supply Chain issued a $2,889.76 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on March 19, 2026, for antidote treatment under firm fixed-price terms. The order is issued against DMS Pharmaceutical Group's single-award Indefinite Delivery Contract under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $499.999 billion program with an ultimate completion date of December...
- The Defense Logistics Agency's Medical Supply Chain issued a $7,224.40 delivery order to DMS Pharmaceutical Group Inc. on March 19, 2026, for antidote treatment pharmaceuticals. The order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $499.999 billion program supporting pharmaceutical supply to Department of Defense healthcare facilities...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 10, 2026, for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), with a ceiling value of $4,361.95. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is placed against the company's single-award Indefinite Delivery Contract under the Defense Logistics Agency's PPV-G GEN V initiative, a $499.999 billion...
- The Defense Logistics Agency issued a $4,966.25 delivery order to DMS Pharmaceutical Group Inc. on March 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. DMS Pharmaceutical Group Inc. is a woman-owned small business. The parent contract, PPV-G GEN V, is a Defense Logistics Agency Indefinite Delivery Contract with a ceiling value of $499,999,999 and an ultimate completion date of December 31, 2036, supporting recurring...
- The Defense Logistics Agency issued a $65,066.40 delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense medical facilities worldwide; DMS Pharmaceutical Group's...
- The Defense Logistics Agency issued a $1,294.01 delivery order to DMS Pharmaceutical Group Inc. on March 18, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical distribution to Department of Defense healthcare facilities worldwide; DMS Pharmaceutical Group holds a...
- The Defense Logistics Agency issued a $4,422.16 delivery order to DMS Pharmaceutical Group Inc. on March 11, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, Illinois. The order carries a firm fixed price structure with an ultimate completion date of March 12, 2026. The PPV-G GEN V is a Defense Logistics Agency indefinite...